Physiology in medicine: Obstructive sleep apnea pathogenesis and treatment-considerations beyond airway anatomy

Journal of Applied Physiology

Volumn 116, Issue 1, 2014, Pages 3-12

  Dempsey, Jerome A ^a   Xie, Ailiang ^a   Patz, David S ^b   Wang, David ^c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b St Mary's Hospital Grand Junction   (United States)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Chemosensitivity; Collapsible airway; Sleep apnea

Indexed keywords

ANIMAL; CHEMOSENSITIVITY; COLLAPSIBLE AIRWAY; HUMAN; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RESPIRATORY SYSTEM; REVIEW; SLEEP DISORDERED BREATHING;

CHEMOSENSITIVITY; COLLAPSIBLE AIRWAY; SLEEP APNEA;

ANIMALS; HUMANS; PHYSIOLOGY; RESPIRATORY SYSTEM; SLEEP APNEA, OBSTRUCTIVE;

EID: 84892755181     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01054.2013     Document Type: Review

References (95)

1. Badr MS, Skatrud JB, Dempsey JA. Determinants of poststimulus potentiation in humans during NREM sleep. J Appl Physiol 73: 1958-1971, 1992.
2. Badr MS, Skatrud JB, Dempsey JA. Effect of chemoreceptor stimulation and inhibition on total pulmonary resistance in humans during NREM sleep. J Appl Physiol 76: 1682-1692, 1994. (Pubitemid 24125690)
3. Badr MS, Toiber F, Skatrud JB, Dempsey J. Pharyngeal narrowing/occlusion during central sleep apnea. J Appl Physiol 78: 1806-1815, 1995.
4. Begle RL, Badr S, Skatrud JB, Dempsey JA. Effect of lung inflation on pulmonary resistance during NREM sleep. Am Rev Respir Dis 141: 854-860, 1990. (Pubitemid 20157709)
5. Berry RB, Kouchi K, Bower J, Prosise G, Light RW. Triazolam in patients with obstructive sleep apnea. Am J Respir Crit Care Med 151: 450-454, 1995.
6. Berry RB, Yamaura EM, Gill K, Reist C. Acute effects of paroxetine on genioglossus activity in obstructive sleep apnea. Sleep 22: 1087-1092, 1999. (Pubitemid 30173983)
7. Bonora M, St John WM, Bledsoe TA. Differential elevation by protriptyline and depression by diazepam of upper airway respiratory motor activity. Am Rev Respir Dis 131: 41-45, 1985. (Pubitemid 15161961)
8. Chow CM, Xi L, Smith CA, Saupe KW, Dempsey JA. A volumedependent apneic threshold during NREM sleep in the dog. J Appl Physiol 76: 2315-2325, 1994. (Pubitemid 24184748)
9. Chowdhuri S, Ghabsha A, Sinha P, Kadri M, Narula S, Badr MS. Treatment of central sleep apnea in U.S. veterans. J Clin Sleep Med 8: 555-563, 2012.
10. Dempsey JA. Crossing the apnoeic threshold: causes and consequences. Exp Physiol 90: 13-24, 2005.
11. Dempsey JA, Veasey SC, Morgan BJ, O'Donnell CP. Pathophysiology of sleep apnea. Physiol Rev 90: 47-112, 2010.
12. Eastwood PR, Barnes M, Walsh JH, Maddison KJ, Hee G, Schwartz AR, Smith PL, Malhotra A, McEvoy RD, Wheatley JR, O'Donoghue FJ, Rochford PD, Churchward T, Campbell MC, Palme CE, Robinson S, Goding GS, Eckert DJ, Jordan AS, Catcheside PG, Tyler L, Antic NA, Worsnop CJ, Kezirian EJ, Hillman DR. Treating obstructive sleep apnea with hypoglossal nerve stimulation. Sleep 34: 1479-1486, 2011.
13. Eckert DJ, Malhotra A. Pathophysiology of adult obstructive sleep apnea. Proc Am Thorac Soc 5: 144-153, 2008. (Pubitemid 351237872)
14. Eckert DJ, Owens RL, Kehlmann GB, Wellman A, Rahangdale S, Yim-Yeh S, White DP, Malhotra A. Eszopiclone increases the respiratory arousal threshold and lowers the apnoea/hypopnoea index in obstructive sleep apnoea patients with a low arousal threshold. Clin Sci (Lond) 120: 505-514, 2011.
15. Eckert DJ, White DP, Jordan AS, Malhotra A, Wellman A. Defining phenotypic causes of obstructive sleep apnea: identification of novel therapeutic targets. Am J Respir Crit Care Med 188: 996-1004: 2013.
16. Edwards BA, Sands SA, Eckert DJ, White DP, Butler JP, Owens RL, Malhotra A, Wellman A. Acetazolamide improves loop gain but not the other physiological traits causing obstructive sleep apnoea. J Physiol 590: 1199-1211, 2012.
17. Eldridge FL. Central neural respiratory stimulatory effect of active respiration. J Appl Physiol 37: 723-735, 1974.
18. Fenik VB, Davies RO, Kubin L. REM sleep-like atonia of hypoglossal (XII) motoneurons is caused by loss of noradrenergic and serotonergic inputs. Am J Respir Crit Care Med 172: 1322-1330, 2005. (Pubitemid 43076572)
19. Franklin KA, Eriksson P, Sahlin C, Lundgren R. Reversal of central sleep apnea with oxygen. Chest 111: 163-169, 1997. (Pubitemid 27043624)
20. Gestreau C, Bevengut M, Dutschmann M. The dual role of the orexin/hypocretin system in modulating wakefulness and respiratory drive. Curr Opin Pulm Med 14: 512-518, 2008.
21. Gilmartin G, McGeehan B, Vigneault K, Daly RW, Manento M, Weiss JW, Thomas RJ. Treatment of positive airway pressure treatmentassociated respiratory instability with enhanced expiratory rebreathing space (EERS). J Clin Sleep Med 6: 529-538, 2010.
22. Grace KP, Hughes SW, Horner RL. Identification of the mechanism mediating genioglossus muscle suppression in REM sleep. Am J Respir Crit Care Med 187: 311-319, 2013.
23. Hanly PJ, Millar TW, Steljes DG, Baert R, Frais MA, Kryger MH. The effect of oxygen on respiration and sleep in patients with congestive heart failure. Ann Intern Med 111: 777-782, 1989. (Pubitemid 19283912)
24. Hanzel DA, Proia NG, Hudgel DW. Response of obstructive sleep apnea to fluoxetine and protriptyline. Chest 100: 416-421, 1991.
25. Haxhiu MA, van Lunteren E, Mitra J, Cherniack NS. Comparison of the response of diaphragm and upper airway dilating muscle activity in sleeping cats. Respir Physiol 70: 183-193, 1987. (Pubitemid 18013960)
26. Hoijer U, Hedner J, Ejnell H, Grunstein R, Odelberg E, Elam M. Nitrazepam in patients with sleep apnoea: a double-blind placebo-controlled study. Eur Respir J 7: 2011-2015, 1994. (Pubitemid 24366293)
27. Horner RL, Hughes SW, Malhotra A. State-dependent and reflex drives to the upper airway: basic physiology with clinical implication. J Appl Physiol. First published August 22, 2013; doi:10.1152/japplphysiol.00531.2013.
28. 2 in rats. J Appl Physiol 92: 878-887, 2002. (Pubitemid 34671061)
29. Hudgel DW. Variable site of airway narrowing among obstructive sleep apnea patients. J Appl Physiol 61: 1403-1409, 1986. (Pubitemid 17179328)
30. Hudgel DW, Chapman KR, Faulks C, Hendricks C. Changes in inspiratory muscle electrical activity and upper airway resistance during periodic breathing induced by hypoxia during sleep. Am Rev Respir Dis 135: 899-906, 1987.
31. Iber C, Davies SF, Chapman RC, Mahowald MM. A possible mechanism for mixed apnea in obstructive sleep apnea. Chest 89: 800-805, 1986. (Pubitemid 16115009)
32. Isono S, Remmers JE, Tanaka A, Sho Y, Sato J, Nishino T. Anatomy of pharynx in patients with obstructive sleep apnea and in normal subjects. J Appl Physiol 82: 1319-1326, 1997. (Pubitemid 27172336)
33. Javaheri S. Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study. Am J Respir Crit Care Med 173: 234-237, 2006. (Pubitemid 43187897)
34. Javaheri S, Ahmed M, Parker TJ, Brown CR. Effects of nasal O2 on sleep-related disordered breathing in ambulatory patients with stable heart failure. Sleep 22: 1101-1106, 1999. (Pubitemid 30173985)
35. Javaheri S, Dempsey JA. Mechanisms of sleep apnea and periodic breathing in systemic heart failure. In: Sleep Medicine Clinics, edited by Javaheri S. Saunders, 2007, p. 623-630.
36. Khoo MC, Kronauer RE, Strohl KP, Slutsky AS. Factors inducing periodic breathing in humans: a general model. J Appl Physiol 53: 644-659, 1982. (Pubitemid 12027236)
37. Kraiczi H, Hedner J, Dahlof P, Ejnell H, Carlson J. Effect of serotonin uptake inhibition on breathing during sleep and daytime symptoms in obstructive sleep apnea. Sleep 22: 61-67, 1999. (Pubitemid 29097899)
38. Krol RC, Knuth SL, Bartlett D Jr. Selective reduction of genioglossal muscle activity by alcohol in normal human subjects. Am Rev Respir Dis 129: 247-250, 1984. (Pubitemid 14189164)
39. Kubin L, Kimura H, Tojima H, Pack AI, Davies RO. Behavior of VRG neurons during the atonia of REM sleep induced by pontine carbachol in decerebrate cats. Brain Res 592: 91-100, 1992.
40. Leiter JC, Knuth SL, Krol RC, Bartlett D Jr. The effect of diazepam on genioglossal muscle activity in normal human subjects. Am Rev Respir Dis 132: 216-219, 1985. (Pubitemid 15229369)
41. Lo YL, Jordan AS, Malhotra A, Wellman A, Heinzer RC, Schory K, Dover L, Fogel RB, White DP. Genioglossal muscle response to CO2 stimulation during NREM sleep. Sleep 29: 470-477, 2006. (Pubitemid 44019936)
42. Loewen A, Ostrowski M, Laprairie J, Atkar R, Gnitecki J, Hanly P, Younes M. Determinants of ventilatory instability in obstructive sleep apnea: inherent or acquired? Sleep 32: 1355-1365, 2009.
43. Lofaso F, Goldenberg F, Thebault C, Janus C, Harf A. Effect of zopiclone on sleep, night-time ventilation, and daytime vigilance in upper airway resistance syndrome. Eur Respir J 10: 2573-2577, 1997. (Pubitemid 28048634)
44. Lorenzi-Filho G, Rankin F, Bies I, Douglas Bradley T. Effects of inhaled carbon dioxide and oxygen on cheyne-stokes respiration in patients with heart failure. Am J Respir Crit Care Med 159: 1490-1498, 1999. (Pubitemid 29227859)
45. Lu B, Budhiraja R, Parthasarathy S. Sedating medications and undiagnosed obstructive sleep apnea: physician determinants and patient consequences. J Clin Sleep Med 1: 367-371, 2005.
46. Manisty CH, Willson K, Wensel R, Whinnett ZI, Davies JE, Oldfield WL, Mayet J, Francis DP. Development of respiratory control instability in heart failure: a novel approach to dissect the pathophysiological mechanisms. J Physiol 577: 387-401, 2006. (Pubitemid 44698263)
47. Marcus NJ, Li YL, Bird CE, Schultz HD, Morgan BJ. Chronic intermittent hypoxia augments chemoreflex control of sympathetic activity: role of the angiotensin II type 1 receptor. Respir Physiol Neurobiol 171: 36-45, 2010.
48. Meza S, Mendez M, Ostrowski M, Younes M. Susceptibility to periodic breathing with assisted ventilation during sleep in normal subjects. J Appl Physiol 85: 1929-1940, 1998. (Pubitemid 28516432)
49. Morgenthaler TI, Kapen S, Lee-Chiong T, Alessi C, Boehlecke B, Brown T, Coleman J, Friedman L, Kapur V, Owens J, Pancer J, Swick T. Practice parameters for the medical therapy of obstructive sleep apnea. Sleep 29: 1031-1035, 2006.
50. Mortimore IL, Douglas NJ. Palatal muscle EMG response to negative pressure in awake sleep apneic and control subjects. Am J Respir Crit Care Med 156: 867-873, 1997. (Pubitemid 27396428)
51. Nakayama H, Smith CA, Rodman JR, Skatrud JB, Dempsey JA. Effect of ventilatory drive on carbon dioxide sensitivity below eupnea during sleep. Am J Respir Crit Care Med 165: 1251-1260, 2002.
52. Nakayama H, Smith CA, Rodman JR, Skatrud JB, Dempsey JA. Carotid body denervation eliminates apnea in response to transient hypocapnia. J Appl Physiol 94: 155-164, 2003. (Pubitemid 36014307)
53. Ng AT, Gotsopoulos H, Qian J, Cistulli PA. Effect of oral appliance therapy on upper airway collapsibility in obstructive sleep apnea. Am J Respir Crit Care Med 168: 238-241, 2003. (Pubitemid 36920980)
54. Nussbaumer-Ochsner Y, Schuepfer N, Ulrich S, Bloch KE. Exacerbation of sleep apnoea by frequent central events in patients with the obstructive sleep apnoea syndrome at altitude: a randomised trial. Thorax 65: 429-435, 2010.
55. Onal E, Burrows DL, Hart RH, Lopata M. Induction of periodic breathing during sleep causes upper airway obstruction in humans. J Appl Physiol 61: 1438-1443, 1986. (Pubitemid 17179332)
56. Paton JF, Sobotka PA, Fudim M, Engelman ZJ, Hart EC, McBryde FD, Abdala AP, Marina N, Gourine AV, Lobo M, Patel N, Burchell A, Ratcliffe L, Nightingale A. The carotid body as a therapeutic target for the treatment of sympathetically mediated diseases. Hypertension 61: 5-13, 2013.
57. Patz D, Spoon M, Corbin R, Patz M, Dover L, Swihart B, White D. The effect of altitude descent on obstructive sleep apnea. Chest 130: 1744-1750, 2006. (Pubitemid 46033428)
58. Peng YJ, Nanduri J, Yuan G, Wang N, Deneris E, Pendyala S, Natarajan V, Kumar GK, Prabhakar NR. NADPH oxidase is required for the sensory plasticity of the carotid body by chronic intermittent hypoxia. J Neurosci 29: 4903-4910, 2009.
59. Pialoux V, Foster GE, Ahmed SB, Beaudin AE, Hanly PJ, Poulin MJ. Losartan abolishes oxidative stress induced by intermittent hypoxia in humans. J Physiol 589: 5529-5537, 2011.
60. 2 during NREM sleep. J Appl Physiol 89: 1275-1282, 2000.
61. Porzionato A, Macchi V, De Caro R, Di Guilio C. Inflammatory and immunomodulatory mechanisms in the carotid body. Respir Physiol Neurobiol 187: 31-40, 2013.
62. Quadri S, Drake C, Hudgel DW. Improvement of idiopathic central sleep apnea with zolpidem. J Clin Sleep Med 5: 122-129, 2009.
63. Rosenberg R, Roach JM, Scharf M, Amato DA. A pilot study evaluating acute use of eszopiclone in patients with mild to moderate obstructive sleep apnea syndrome. Sleep Med 8: 464-470, 2007. (Pubitemid 46971996)
64. Salazar-Grueso EF, Rosenberg RS, Roos RP. Sleep apnea in olivopontocerebellar degeneration: treatment with trazodone. Ann Neurol 23: 399-401, 1988. (Pubitemid 18098251)
65. Salloum A, Rowley JA, Mateika JH, Chowdhuri S, Omran Q, Badr MS. Increased propensity for central apnea in patients with obstructive sleep apnea: effect of nasal continuous positive airway pressure. Am J Respir Crit Care Med 181: 189-193, 2010.
66. Sampol G, Rodes G, Rios J, Romero O, Lloberes P, Morell F. [Acute hypercapnic respiratory failure in patients with sleep apneas]. Arch Bronconeumol 46: 466-472, 2010.
67. Sands SA, Edwards BA, Kee K, Turton A, Skuza EM, Roebuck T, O'Driscoll DM, Hamilton GS, Naughton MT, Berger PJ. Loop gain as a means to predict a positive airway pressure suppression of Cheyne-Stokes respiration in patients with heart failure. Am J Respir Crit Care Med 184: 1067-1075, 2011.
68. Sankri-Tarbichi AG, Grullon K, Badr MS. Effects of clonidine on breathing during sleep and susceptibility to central apnoea. Respir Physiol Neurobiol 185: 356-361, 2013.
69. Schmidt HS. L-tryptophan in the treatment of impaired respiration in sleep. Bull Eur Physiopathol Respir 19: 625-629, 1983. (Pubitemid 14223649)
70. Schwartz AR, Gold AR, Schubert N, Stryzak A, Wise RA, Permutt S, Smith PL. Effect of weight loss on upper airway collapsibility in obstructive sleep apnea. Am Rev Respir Dis 144: 494-498, 1991.
71. Schwartz AR, Smith PL, Wise RA, Gold AR, Permutt S. Induction of upper airway occlusion in sleeping individuals with subatmospheric nasal pressure. J Appl Physiol 64: 535-542, 1988. (Pubitemid 18069903)
72. Sériès F. Can improving sleep influence sleep-disordered breathing? Drugs 69, Suppl 2: 77-91, 2009.
73. Smith CA, Chenuel BJ, Henderson KS, Dempsey JA. The apneic threshold during non-REM sleep in dogs: sensitivity of carotid body vs. central chemoreceptors. J Appl Physiol 103: 578-586, 2007. (Pubitemid 47204976)
74. Sood S, Liu X, Liu H, Nolan P, Horner RL. 5-HT at hypoglossal motor nucleus and respiratory control of genioglossus muscle in anesthetized rats. Respir Physiol Neurobiol 138: 205-221, 2003. (Pubitemid 37372030)
75. Sutton JR, Houston CS, Mansell AL, McFadden MD, Hackett PM, Rigg JR, Powles AC. Effect of acetazolamide on hypoxemia during sleep at high altitude. N Engl J Med 301: 1329-1331, 1979. (Pubitemid 10181384)
76. Tagaito Y, Isono S, Remmers JE, Tanaka A, Nishino T. Lung volume and collapsibility of the passive pharynx in patients with sleep-disordered breathing. J Appl Physiol 103: 1379-1385, 2007. (Pubitemid 47605977)
77. Thomas RJ. The chemoreflex and sleep-disordered breathing: man and machine vs. the beast. Sleep Med 12: 533-535, 2011.
78. Thomas RJ, Rosen BR, Stern CE, Weiss JW, Kwong KK. Functional imaging of working memory in obstructive sleep-disordered breathing. J Appl Physiol 98: 2226-2234, 2005. (Pubitemid 40726919)
79. Thomas RJ, Terzano MG, Parrino L, Weiss JW. Obstructive sleepdisordered breathing with a dominant cyclic alternating pattern-a recognizable polysomnographic variant with practical clinical implications. Sleep 27: 229-234, 2004. (Pubitemid 44138830)
80. Verbraecken J, Willemen M, De Cock W, Wittesaele W, Govaert K, Van de Heyning P, De Backer W. Influence of longterm CPAP therapy on CO(2) drive in patients with obstructive sleep apnea. Respir Physiol 123: 121-130, 2000.
81. Wang D, Eckert DJ, Grunstein RR. Drug effects on ventilatory control and upper airway physiology related to sleep apnea. Respir Physiol Neurobiol 188: 257-266, 2013.
82. Wang D, Marshall NS, Duffin J, Yee BJ, Wong KK, Noori N, Ng SS, Grunstein RR. Phenotyping interindividual variability in obstructive sleep apnoea response to temazepam using ventilatory chemoreflexes during wakefulness. J Sleep Res 20: 526-532, 2011.
83. Warner G, Skatrud JB, Dempsey JA. Effect of hypoxia-induced periodic breathing on upper airway obstruction during sleep. J Appl Physiol 62: 2201-2211, 1987. (Pubitemid 17093429)
84. Weaver TE, Grunstein RR. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc 5: 173-178, 2008. (Pubitemid 351237875)
85. Wellman A, Eckert DJ, Jordan AS, Edwards BA, Passaglia CL, Jackson AC, Gautam S, Owens RL, Malhotra A, White DP. A method for measuring and modeling the physiological traits causing obstructive sleep apnea. J Appl Physiol 110: 1627-1637, 2011.
86. Wellman A, Edwards BA, Sands SA, Owens RL, Nemati S, Butler J, Passaglia CL, Jackson AC, Malhotra A, White DP. A simplified method for determining phenotypic traits in patients with obstructive sleep apnea. J Appl Physiol 114: 911-922, 2013.
87. Wellman A, Jordan AS, Malhotra A, Fogel RB, Katz ES, Schory K, Edwards JK, White DP. Ventilatory control and airway anatomy in obstructive sleep apnea. Am J Respir Crit Care Med 170: 1225-1232, 2004. (Pubitemid 39577382)
88. Wellman A, Malhotra A, Jordan AS, Stevenson KE, Gautam S, White DP. Effect of oxygen in obstructive sleep apnea: role of loop gain. Respir Physiol Neurobiol 162: 144-151, 2008.
89. Wirth KJ, Steinmeyer K, Ruetten H. Sensitization of upper airway mechanoreceptors as a new pharmacologic principle to treat obstructive sleep apnea: investigations with AVE0118 in anesthetized pigs. Sleep 36: 699-708, 2013.
90. Xie A, Skatrud JB, Dempsey JA. Effect of hypoxia on the hypopnoeic and apnoeic threshold for CO(2) in sleeping humans. J Physiol 535: 269-278, 2001. (Pubitemid 32782743)
91. 2 on the susceptibility to posthyperventilation apnea during sleep. J Appl Physiol 100: 171-177, 2006. (Pubitemid 43671105)
92. Xie A, Teodorescu M, Pegelow DF, Teodorescu MC, Gong Y, Fedie JE, Dempsey JA. Effects of stabilizing or increasing respiratory motor outputs on obstructive sleep apnea. J Appl Physiol 115: 22-33, 2013.
93. Younes M. Contributions of upper airway mechanics and control mechanisms to severity of obstructive apnea. Am J Respir Crit Care Med 168: 645-658, 2003. (Pubitemid 37175967)
94. Younes M. Role of respiratory control mechanisms in the pathogenesis of obstructive sleep disorders. J Appl Physiol 105: 1389-1405, 2008.
95. Younes M, Ostrowski M, Atkar R, Laprairie J, Siemens A, Hanly P. Mechanisms of breathing instability in patients with obstructive sleep apnea. J Appl Physiol 103: 1929-1941, 2007. (Pubitemid 350232374)